| |
 |
SYM |
Description |
 |
|
private |
Medical device company developing obesity treatments. |
 |
|
|
|
|
|
|
|
Private |
Endoscopically Implantable Devices for the Treatment of Metabolic Disorders |
|
|
|
|
|
|
|
VIVUS |
|
Mountain View, CA |
USA |
|
VVUS |
Products used to treat sexual function. |
|
|
|
|
|
|
|
|
Private |
Medical device system for non-invasively treating obesity. |
|
|
|
|
|
|
|
|
Private |
Minimally Invasive Treatments for Obesity and Gastrointestinal Conditions |
|
|
|
|
|
|
|
|
Private |
Services for biopharmaceutical companies developing drugs targeting diabetes and obesity. |
|
|
|
|
|
|
|
|
Private |
Obesity Disease Management for the comprehensive, cost-effective treatment for obesity. |
|
|
|
|
|
|
|
|
Private |
Neuromodulation therapy for chronic obesity. |
|
|
|
|
|
|
|
|
CXSP |
ChemGenex intends to develop targeted medicines for cancer, diabetes, obesity and depression |
|
|
|
|
|
|
|
|
Private |
Treatment of obesity and other metabolic diseases. |
|
|
|
|
|
|
|
|
Private |
Develops treatments for obesity and other gastrointestinal disorders |
|
|
|
|
|
|
|
|
Private |
Developing novel obesity device for nonsurgical treatment |
|
|
|
|
|
|
|
|
Private |
Drugs for diabetes and obesity. |
|
|
|
|
|
|
|
|
Private |
Small molecule pharmaceuticals for obesity and its co-morbidities. |
|
|
|
|
|
|
|
|
Private |
Endoscopically delivered gastric pacemaker for obesity treatment. |
|
|
|
|
|
|
|
|
Private |
Researchers at our Obesity Research Center are working at the cutting edge of obesity science. |
|
|
|
|
|
|
|
|
ETRM |
Medical devices to treat obesity and gastrointestinal disorders. |
|
|
|
|
|
|
|
|
Private |
Medical device company focused on nonsurgical, nonpharmacologic therapies for obesity. |
|
|
|
|
|
|
|
|
Private |
Products in the areas of anti-infectives, obesity and oncology. |
|
|
|
|
|
|
|
|
SEK |
Drug research with expertise in the fields of obesity, diabetes and inflammation. |
|
|
|
|
|
|
|
|
Private |
Drugs for obesity, hypercholesterolemia and type II diabetes. |
|
|
|
|
|
|
|
|
Private |
NUMBER DISCONNECTED
Minimally invasive medical devices for the treatment of obesity.
|
|
|
|
|
|
|
|
|
OREX |
Anti-obesity drug development. |
|
|
|
|
|
|
|
|
Private |
Therapies for metabolic disorders, such as obesity and diabetes. |
|
|
|
|
|
|
|
|
Private |
Liposuction and Surgery for obesity |
|
|
|
|
|
|
|
|
Private |
Defining and validating drug compounds and target genes in obesity, diabetes, and similar fields. |
|
|
|
|
|
|
|
|
Private |
Treatment of human muscular degenerative diseases, as well as Type II diabetes and obesity. |
|
|
|
|
|
|
|
|
NRGN |
Small molecule drug candidates for pain, insomnia, inflammation, depression, and obesity. |
|
|
|
|
|
|
|
|
Private |
Drug discovery in the areas of pain and obesity. |
|
|
|
|
|
|
|
|
private |
|
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
